BMS Exec Ohura Appointed as CEO of GHIT Fund

March 29, 2019
New GHIT Fund CEO Catherine Ohura The Global Health Innovative Technology Fund (GHIT Fund) said on March 28 that it has named Catherine Ohura, executive officer of the Japan arm of Bristol-Myers Squibb, as its new CEO and executive director,...read more